IRIS UniCatt

Grieco, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.077
EU - Europa 8.632
AS - Asia 8.020
SA - Sud America 1.671
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 189
OC - Oceania 37
Totale 30.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.755
SG - Singapore 3.653
DE - Germania 3.215
CN - Cina 1.930
SE - Svezia 1.381
BR - Brasile 1.348
IT - Italia 943
VN - Vietnam 733
UA - Ucraina 714
FR - Francia 609
GB - Regno Unito 410
IE - Irlanda 390
FI - Finlandia 278
ID - Indonesia 272
IN - India 265
RU - Federazione Russa 218
TR - Turchia 208
JP - Giappone 204
HK - Hong Kong 166
BD - Bangladesh 159
CA - Canada 157
AR - Argentina 121
PL - Polonia 115
IQ - Iraq 84
MX - Messico 61
NL - Olanda 56
AT - Austria 52
EC - Ecuador 52
ZA - Sudafrica 48
ES - Italia 47
BE - Belgio 46
CO - Colombia 44
KR - Corea 35
SA - Arabia Saudita 33
PK - Pakistan 32
AU - Australia 29
IR - Iran 29
VE - Venezuela 29
MA - Marocco 27
PH - Filippine 26
AE - Emirati Arabi Uniti 25
UZ - Uzbekistan 25
EU - Europa 22
KE - Kenya 22
CL - Cile 20
JO - Giordania 20
RO - Romania 20
EG - Egitto 19
PE - Perù 19
PT - Portogallo 17
CH - Svizzera 16
PY - Paraguay 16
CZ - Repubblica Ceca 15
DZ - Algeria 15
JM - Giamaica 15
MY - Malesia 15
TT - Trinidad e Tobago 15
LT - Lituania 14
CI - Costa d'Avorio 13
PA - Panama 13
IL - Israele 12
AZ - Azerbaigian 11
BO - Bolivia 11
CR - Costa Rica 11
TN - Tunisia 11
AL - Albania 10
SV - El Salvador 10
TH - Thailandia 10
DK - Danimarca 9
HU - Ungheria 8
NI - Nicaragua 8
UY - Uruguay 8
HN - Honduras 7
KG - Kirghizistan 7
NG - Nigeria 7
NP - Nepal 7
OM - Oman 7
GR - Grecia 6
KZ - Kazakistan 6
LB - Libano 6
LK - Sri Lanka 6
NZ - Nuova Zelanda 6
BG - Bulgaria 5
BZ - Belize 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GE - Georgia 5
KW - Kuwait 5
MK - Macedonia 5
PR - Porto Rico 5
BY - Bielorussia 4
EE - Estonia 4
GT - Guatemala 4
MD - Moldavia 4
SI - Slovenia 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
CY - Cipro 3
IS - Islanda 3
Totale 30.590
Salva come PNG Salva come JPEG
Città #
Singapore 1.911
Chandler 1.366
Ashburn 1.233
San Jose 1.156
Jacksonville 416
Dublin 387
Beijing 371
San Mateo 334
New York 290
Ho Chi Minh City 260
Frankfurt am Main 250
Nanjing 239
Jakarta 238
Los Angeles 234
Ann Arbor 223
Dallas 210
Lauterbourg 209
Wilmington 197
Boston 193
Tokyo 184
Nürnberg 180
Houston 173
Hefei 166
Hanoi 159
Munich 158
Milan 153
Izmir 152
Cattolica 151
Rome 150
Hong Kong 142
Dearborn 139
São Paulo 127
Princeton 125
Woodbridge 121
Moscow 117
Chicago 110
The Dalles 109
Marseille 101
Nanchang 99
Boardman 97
Helsinki 95
Santa Clara 87
Buffalo 84
Seattle 80
Redwood City 68
Lawrence 66
Redmond 63
Fairfield 57
Tianjin 57
Council Bluffs 55
Hebei 55
Kraków 55
Brooklyn 53
Tukwila 53
London 52
Atlanta 47
Mountain View 47
Paris 47
Bremen 45
Brussels 45
Shenyang 45
Rio de Janeiro 43
Kunming 42
Phoenix 41
Denver 39
Kent 39
Orem 39
University Park 39
Da Nang 38
Warsaw 38
Zhengzhou 38
Guangzhou 37
Jiaxing 37
San Francisco 37
Hangzhou 36
Norwalk 36
Changsha 35
Montreal 35
Augusta 34
Baghdad 34
Nuremberg 34
Toronto 34
Seoul 32
Turku 32
Washington 32
Haiphong 31
Belo Horizonte 30
Dhaka 28
Fremont 28
Düsseldorf 27
Jinan 27
Poplar 26
St Louis 26
Amsterdam 25
Brasília 25
Memphis 25
Shanghai 25
Stockholm 25
Pune 24
Cambridge 23
Totale 15.162
Salva come PNG Salva come JPEG
Nome #
Gastrointestinal amyloidosis: a case of chronic diarrhoea. 355
Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. 333
A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease 312
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 301
A phase II study of sunitinib in advanced hepatocellular carcinoma 281
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study 276
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 268
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? 268
13C-methionine breath tests for mitochondrial liver function assessment. 266
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 253
Cholestatic hepatitis due to ticlopidine: clinical and histological recovery after drug withdrawal. Case report and review of the literature 247
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 242
-Hepatic steatosis and vascular disease 241
Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis 241
Abdominal angina due to recurrence of cancer of the papilla of vater: a case report. 234
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 221
134C-breath tests in the study of mitochondrial liver function 220
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 218
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 215
Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels 215
Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE) 213
13C-breath tests in the study of microsomial liver function 209
recurrent acute hepatitis associated with use of cetrizine 206
Non-alcoholic fatty liver disease is associated with high prevalence of gastro-oesophageal reflux symptoms 204
13C-methionine breath tests for mitochondrial liver function assessment 197
The Effect of CYP, GST, and SULT Polymorphisms and Their Interaction with Smoking on the Risk of Hepatocellular Carcinoma 194
Epicardial fat thickness correlates with body fat stores, insulin resistance and alanine aminotransferase in patients affected by nonalcoholic steatohepatitis (NASH) 193
Liver transplantation in patients with alcoholic liver disease: A retrospective study 193
Effect of sildenafil on diabetic gastropathy. 191
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 190
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver 183
High Prevalence and Gender-Related Differences of Gastrointestinal Manifestations in a Cohort of DM1 Patients: A Perspective, Cross-Sectional Study 183
Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease 182
Potential use of liver function breath tests in the clinical practice. 181
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma 181
Contrast-enhanced ultrasound in the short-term evaluation of hepatocellular carcinoma after locoregional treatment 181
Noninvasive assessment of fibrosis in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). 180
gc) Celiac disease in the 21st century: issues of under- and over-diagnosis 180
Hepatitis C in the elderly: A multicentre cross-sectional study by the Italian Association for the Study of the Liver 179
[The treatment of hepatocellular carcinoma: an update] 179
Erythrocyte viscoelastic recovery after liver transplantation in a cirrhotic patient affected by spur cell anaemia 179
[Oxidative stress in metabolic syndrome and nonalcoholic steatohepatitis. Is it possible a role for vitamins in clinical practice?] 178
Vanishing-recurrent benign liver lesions 176
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival 175
Cystic lymphangioma of the mesentery and hyposplenism in celiac disease. 174
L'insufficienza epatica: algoritmi diagnostici e trattamenti medici 173
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 170
-Fatty liver and drugs 168
An update on clinical applications of hepatospecific contrast media in magnetic resonance imaging of liver parenchyma 168
Cryoglobulinemia: a true internistic disease? 167
13C-breath tests in the study of mitochondrial liver function 166
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 166
Genetic susceptibility of increased intestinal permeability is associated with progressive liver disease and diabetes in patients with non-alcoholic fatty liver disease 160
Noninvasive Evaluation of Clinically Significant Portal Hypertension in Patients with Liver Cirrhosis: The Role of Contrast-Enhanced Ultrasound Perfusion Imaging and Elastography 159
Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature. 159
Faecal calprotectin concentrations in untreated coeliac patients 159
Low-dose lactose in drugs neither increases breath hydrogen excretion nor causes gastrointestinal symptoms. 159
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 158
gastroesophageal reflux disease: facts and uncertaines 156
Project for interventional Oncology LArge-database in liveR Hepatocellular carcinoma - Preliminary CT-based radiomic analysis (POLAR Liver 1.1) 155
Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma 154
Severe giant cell arteritis associated with essential thrombocythaemia. 153
Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. 152
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 152
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 152
A case-control study on the effects of the apolipoprotein E genotypes in nonalcoholic fatty liver disease 151
Mediterranean diet and the prevention of non-alcoholic fatty liver disease: Results from a case-control study 151
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 150
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial 149
FAECAL CALPROTECTIN CONCENTRATIONS IN UNTREATED CELIAC PATIENTS 148
Tromboembolism and breast cancer: the hidden risk for patient and physician 148
Evaluation of the albumin-gamma-glutamyl transferase isoenzyme as a diagnostic marker of hepatocellular carcinoma-complicating liver cirrhosis. 148
Gallstone disease is associated with more severe liver damage in patients with non-alcoholic Fatty liver disease 147
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 147
Liver resection for hepatocellular carcinoma in patient with situs inversus viscerum 147
Quando e perché fermarsi nelle terapie: l’opinione del clinico e del bioeticista sui casi di HCC avanzato. 146
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 145
Antipyrine clearance in chronic and neoplastic liver diseases: a study of 518 patients. 145
Impact of new DAA therapy on real clinical practice: A multicenter region-wide cohort study 145
-Nonalcoholic fatty liver disease: defining a common problem 144
The role of elastography in non-Alcoholic fatty liver disease 144
Advanced colon cancer: staging and prognosis by CEA test 142
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 142
A novel ABCB11 variant in compound heterozygosity: BRIC2 or PFIC2? 139
Braised liver with herbs: the risks of naturopathic hepatoprotection. 139
Comment on "the role of endoscopic ultrasound in the evaluation of chronic mesenteric ischaemia" 139
Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma 139
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 136
[Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients] 135
Enhanced liver fibrosis test as a reliable tool for assessing fibrosis in nonalcoholic fatty liver disease in a clinical setting 135
Alcoholic and nonalcoholic forms of fatty liver disease. 134
Socio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisoners. 134
Severe acute hepatitis after resumption of interferon-Beta therapy for multiple sclerosis: a word of caution. 134
Liver transplantation in alcoholic patients: Impact of an alcohol addiction unit within a liver transplant center 133
Liver transplantation for severe alcoholic hepatitis: A multicenter Italian study 132
Gender affects 13C-ketoisocaproic acid breath test 132
Letter to the Editor: Suboptimal performance of CAR-OLT score to predict 1-year risk of cardiovascular events after liver transplantation 132
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 130
Balloon-Occluded Radiofrequency Ablation as Bridge to TACE in the Treatment of Advanced HCC with Arterioportal Shunt 128
Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis: Evidence and uncertainties 127
Totale 18.011
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.863
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.863
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.528 0 0 46 177 124 43 29 288 62 89 320 350
2022/20233.745 493 492 290 543 284 450 163 341 432 51 152 54
2023/20241.879 120 560 77 89 80 272 119 64 23 76 162 237
2024/20253.887 100 108 335 121 305 146 88 213 608 402 776 685
2025/202610.320 1.537 309 673 1.110 1.732 636 1.801 490 703 707 357 265
2026/20271.849 552 928 369 0 0 0 0 0 0 0 0 0
Totale 30.968